Agenus
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agenus and other ETFs, options, and stocks.About AGEN
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777.
CEOGaro H. Armen
CEOGaro H. Armen
Employees316
Employees316
HeadquartersLexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded1994
Founded1994
Employees316
Employees316
AGEN Key Statistics
Market cap155.76M
Market cap155.76M
Price-Earnings ratio-2.17
Price-Earnings ratio-2.17
Dividend yield—
Dividend yield—
Average volume745.73K
Average volume745.73K
High today$4.87
High today$4.87
Low today$4.58
Low today$4.58
Open price$4.59
Open price$4.59
Volume848.48K
Volume848.48K
52 Week high$7.34
52 Week high$7.34
52 Week low$1.38
52 Week low$1.38
Stock Snapshot
Agenus(AGEN) stock is priced at $4.58, giving the company a market capitalization of 155.76M. It carries a P/E multiple of -2.17.
On 2026-01-14, Agenus(AGEN) stock traded between a low of $4.58 and a high of $4.87. Shares are currently priced at $4.58, which is 0.0% above the low and -6.0% below the high.
Agenus(AGEN) shares are trading with a volume of 848.48K, against a daily average of 745.73K.
During the past year, Agenus(AGEN) stock moved between $1.38 at its lowest and $7.34 at its peak.
During the past year, Agenus(AGEN) stock moved between $1.38 at its lowest and $7.34 at its peak.
People also own
Based on the portfolios of people who own AGEN. This list is generated using Robinhood data, and it’s not a recommendation.